ArticleInternational journal of molecular sciences2024

Immunohistochemical Expression of p53 and FGFR3 Predicts Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

Yujiro Nagata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.